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Functional Analysis of the Role of Toxoplasma gondii Nucleoside
Triphosphate Hydrolases I and II in Acute Mouse Virulence and
Immune Suppression
Philipp Olias, L. David Sibley

Bioluminescent reporter assays have been widely used to study the effect of Toxoplasma gondii on host gene expression. In the
present study, we extend these studies by engineering novel reporter cell lines containing a gamma-activated sequence (GAS)
element driving firefly luciferase (FLUC). In RAW264.7 macrophages, T. gondii type I strain (GT1) infection blocked interferon
gamma (IFN-␥)-induced FLUC activity to a significantly greater extent than infection by type II (ME49) and type III (CTG)
strains. Quantitative trait locus (QTL) analysis of progeny from a prior genetic cross identified a genomic region on chromosome XII that correlated with the observed strain-dependent phenotype. This QTL region contains two isoforms of the T. gondii
enzyme nucleoside triphosphate hydrolase (NTPase) that were the prime candidates for mediating the observed strain-specific
effect. Using reverse genetic analysis we show that deletion of NTPase I from a type I strain (RH) background restored the higher
luciferase levels seen in the type II (ME49) strain. Rather than an effect on IFN-␥-dependent transcription, our data suggest
that NTPase I was responsible for the strain-dependent difference in FLUC activity due to hydrolysis of ATP. We further show
that NTPases I and II were not essential for tachyzoite growth in vitro or virulence in mice. Our study reveals that although T.
gondii NTPases are not essential for immune evasion, they can affect ATP-dependent reporters. Importantly, this limitation was
overcome using an ATP-independent Gaussia luciferase, which provides a more appropriate reporter for use with T. gondii infection studies.

T

oxoplasma gondii is an obligate intracellular protozoan parasite that can infect virtually all warm-blooded animals and
humans (1). It is the cause of toxoplasmosis, a serious infectious
disease in congenitally infected children and immunosuppressed
individuals (2), and an important pathogen in livestock (3). Innate immunity provides a critical defense barrier against T. gondii
infection and interferon gamma (IFN-␥) plays a key role in this
defense (4). In IFN-␥-activated cells, the transcription factor signal transduction and activator of transcription factor 1 (STAT1)
translocates to the nucleus and binds as a homodimer to gammaactivated sequence (GAS) sites in promoters of IFN-␥-responsive
genes such as IFN regulatory factor 1 (IRF1), major histocompatibility complex type II (MHC-II), or immunity-related GTPases
(5). IRF1 is an early response gene of the STAT1 pathway and a
transcription coactivator of genes induced by IFN-␥ (6). Over the
past few years, multiple virulence factors of the parasite have been
identified that work in concert to block effectors that have been
preactivated by IFN-␥ and which are upregulated by the STAT1
pathway (7). Central is the effector rhoptry protein 18, which has
been identified as a major virulence determinant in the mouse by
quantitative trait locus (QTL) analysis based on genetic crosses
between T. gondii strains (8, 9). Virulent type I strains also contain
a unique isoform of a nucleoside triphosphate hydrolase (NTPase) I, whereas NTPase II is universally present in all T. gondii
strains (10). This difference has led to the speculation that NTPase
I might also constitute an important virulence factor, and this
possibility is supported by the fact that attempts to knock out
NTPase I have been unsuccessful so far (11). The biological roles
of NTPases I and II, however, still remain unknown. Interestingly,
although these enzymes have only 16 amino acid differences between them (10), NTPase I preferentially hydrolyzes triphosphate
nucleosides, while NTPase II hydrolyzes tri- and diphosphate
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nucleosides (10). Additionally, NTPase I cleaves ATP at 4.5 times
the rate of NTPase II (10, 12). In vitro, it has been shown that
dithiol compounds such as dithiothreitol (DTT) are essential for
activation of the NTPases (13).
In cells that are infected prior to IFN-␥ activation, T. gondii
blocks IFN-␥-dependent gene transcription by an unknown effector mechanism (14, 15). This inhibition occurs independent of
cell type in both mouse and human cells as shown by the inhibition of multiple genes that are upregulated by the STAT1 pathway
such as IRF1, MHC-II, MHC transactivator (CIITA), and inducible nitric oxide synthase (i.e., the NOS2 gene) (14–16). Recently,
a GAS element driven firefly luciferase (FLUC) reporter was used
to measure strain-dependent inhibition in HEK293 cells treated
with IFN-␥. Interestingly, no difference was detected between the
three main clonal T. gondii lineage types I, II, and III (17), a finding consistent with previous transcriptional studies indicating
that all three strain types suppress IFN-␥-dependent transcription
(14, 15).
In the present study, we identified a strain-dependent differ-
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MATERIALS AND METHODS
Parasite and host cell strains. Toxoplasma gondii strains were maintained
as tachyzoites by serial passage on human foreskin fibroblast (HFF) cell
monolayers in regular growth media based on Dulbecco modified Eagle
medium (Life Technologies, Carlsbad, CA) supplemented with 10% fetal
bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA), 2 mM
L-glutamine, 10 mM HEPES (pH 7.5), and gentamicin (20 g/ml) at 37°C
under 5% CO2. Parasites used in experiments were harvested after natural
egress and separated from host cell debris by a 3-m-pore-size nucleopore filter. T. gondii GT1 (ATCC 50853; type I), ME49 (ATCC 50611; type
II), and CTG (ATCC 50842; type III) were used as representative type
strains. A collection of progeny from a previous genetic cross between I
(GT1SNFr) ⫻ II (ME49FUDRr) strains (18) was used for QTL mapping. RH
(type I) strain expressing green fluorescent protein (GFP) (RH⌬hxgprt/
GFP; ATCC 50940) was used for the construction of CRISPR/Cas9 (19)
guided NTPase I and II gene disruptant mutants. All parasite strains and
cell lines were routinely diagnosed negative for Mycoplasma contamination using the e-Myco plus mycoplasma PCR detection kit (Boca Scientific, Boca Raton, FL).
Reporter cell line construction. All plasmids and primers used in this
study are listed in Tables S1 to S3 in the supplemental material. RAW264.7
macrophages and HeLa cells were transduced with lentiviral particles containing four tandem GAS elements (5=-AGTTTCATATTACTCTAAAT
C-3=) fused to a murine cytomegalovirus (mCMV) promoter driving a
FLUC (pGreenFire1-GAS-EF1-puro; System Biosciences, San Francisco,
CA). Permanent cell lines were established under puromycin selection
and single colonies were selected for activation by IFN-␥. Gibson assembly (Gibson assembly cloning kit; NEB, Ipswich, MA) was used to construct the GLUC expression vector. In short, five tandem GAS elements
were fused to a mCMV promoter that is driving GLUC. A neomycin
resistance cassette was added for stable cell transfection (pGLUC5⫻GAS-mCMV-neoR). After transfection into RAW264.7 macrophages
with Lipofectamine LTX (Thermo Fisher Scientific, Waltham, MA), stable colonies were selected under G418 (Sigma, St. Louis, MO) and tested
for activation of GLUC by IFN-␥.
FLUC and GLUC reporter assays. Reporter cells were plated into
black 96-well plates with clear bottoms (BD Biosciences, Franklin Lakes,
NJ) in regular growth media. Confluent monolayers were infected in triplicate with parasites at various multiplicities of infection (MOIs). At 2 h
after infection, the cells were activated with 100 U of murine and human
IFN-␥/ml, respectively, for 18 h. Cells containing FLUC were washed once
with phosphate-buffered saline (PBS) and lysed with either cell culture
lysis reagent (Promega, Madison, WI) or dithiothreitol (DTT)-free standard lysis buffer (100 mM potassium phosphate [pH 7.8], 1 mM EDTA, 7
mM 2-mercaptoethanol, 10% [vol/vol] glycerol) (20). Cells containing
GLUC were lysed with luciferase cell lysis buffer (NEB). The luminescence
intensity was measured after the addition of 100 l of firefly luciferase
assay substrate (Promega) after the addition of 50 l of Gaussia luciferase
assay buffer (NEB), according to the manufacturer’s instructions. Luminescence was detected on a Cytation 3 Cell Imaging Multi-Mode plate
reader (Biotek, Winooski, VT), and data were normalized to the uninfected, stimulated sample. For strain comparisons, we used the mean lu-
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minescence value generated at an MOI, at which the infection rate was
⬃50% as determined by a quantitative invasion assay (21) that was performed in parallel. Samples were averaged over two to three biological
replicates, each with three technical replicates.
QTL analysis. For QTL association mapping, the ability of strains to
interfere with the FLUC reporter system in RAW264.7 macrophages was
expressed as a ratio of the uninfected, activated control. Each strain was
measured at a range of five different MOIs in triplicate using a 96-well
plate format. At 2 h after infection, the cells were activated with 100 U of
IFN-␥/ml overnight for 18 h, after which the cells were lysed with lysis
buffer (Promega), and the luciferase activity was measured. Log(1/P) values were plotted along the genome-wide coordinates of the 1,603 single nucleotide polymorphism markers described previously (18), with genomewide significance thresholds determined from 1,000 permutations. For fine
mapping the region in the identified QTL, we isolated and characterized new
progeny from a previous genetic cross (18). These new progeny clones were
typed with markers on chromosome XII using previously published markers
(22) and at new genomic regions that were PCR amplified and sequenced
with newly designed primers (see Table S2 in the supplemental material).
Single nucleotide polymorphisms within these new markers were used to
genotype the progeny with respect to the parental alleles.
CRISPR/Cas9-mediated generation of NTPase disruptant mutants.
For disruption of the NTPase locus, two CRISPR/Cas9 plasmids containing specific guide RNA sequences (see Table S3 in the supplemental material) matching either NTPase I or NTPase II were constructed by Q5
polymerase PCR mutagenesis (NEB), as described previously (19). After
transfection of the plasmids, together with amplicons containing either
hypoxanthine, xanthine, guanosine, phosphoribosyl transferase (HXGPRT), or dihydrofolate reductase (DHFR) by electroporation, transgenic
parasites were selected in mycophenolic acid (25 g/ml) and xanthine (50
g/ml) and 3 mM pyrimethamine, respectively. Single-cell clones were
obtained by limiting dilution, and gene disruption was verified by diagnostic PCR using primers listed in Table S3 in the supplemental material.
PCRs were performed using Taq DNA polymerase (Sigma). Products
were analyzed by electrophoresis in agarose gels with ethidium bromide.
Western blot analysis. PCR-positive clones were further analyzed by
Western blotting to confirm the absence of NTPase protein. In brief, T.
gondii tachyzoite lysates were resolved on SDS-PAGE gels and subsequently transferred to nitrocellulose. Blotted proteins were blocked in
LICOR blocking buffer (LICOR Biosciences, Lincoln, NE) and detected
with rabbit anti-NTPase (23) and mouse anti-GRA7 (24) primary antibodies incubated in 5% milk in PBS for 1 h. Secondary antibodies (LICOR
Biosciences) conjugated to IRDye 680CW (donkey anti-rabbit IgG) and
IRDye 800CW (donkey anti-mouse IgG) were used to visualize signals on
an Odyssey infrared imager (LICOR Biosciences).
Plaque and mouse virulence assay. Mice were kept in an Association
for Assessment and Accreditation of Laboratory Animal Care-approved
facility. The Institutional Care Committee at Washington University
School of Medicine approved all experiments. Groups of five female CD1
mice were injected intraperitoneally with 200 parasites. The survival of the
animals was monitored over 30 days. The animal experiment was repeated
once, and the cumulative mortality of both experiments (n ⫽ 10 mice per
group) was plotted as Kaplan-Meyer curves in Prism (GraphPad Software, Inc., La Jolla, CA), as previously described (7). To test for parasite
viability, parasites were inoculated onto HFF cell monolayers grown in
six-well plates for 7 days without movement. Subsequently, cells were
fixed with 70% ethanol and stained with 0.1% crystal violet. Plates were
then scanned using an Epson scanner.
Immunofluorescence assay. To assess the inhibition of the STAT1
pathway by the wild type and by NTPase disruptant mutants, HFF cells
were infected for 16 h and subsequently activated with 100 U of IFN-␥/ml
for 5 h. The cells were fixed with 4% formaldehyde in PBS for 15 min,
permeabilized with 0.1% Triton X-100 for 15 min at room temperature,
and blocked in 10% FBS for 20 min. Subsequently, samples were incubated with anti-IRF1 (Cell Signaling, Danvers, MA), washed in PBS, and
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ence using a similar GAS-driven FLUC reporter in RAW264.7
macrophages and HeLa cells. We identified the genomic locus
responsible for the observed phenotype by QTL analysis of a previous genetic cross and generated disruptant mutants of the two
most likely candidate genes of that locus: NTPase I and NTPase II.
However, rather than being due to a transcriptional difference,
our studies show that the FLUC assay is prone to artifacts due to
the strong ATP hydrolysis activity of NTPases. This problem was
circumvented by using a Gaussia luciferase (GLUC) that does not
rely on ATP, thus confirming that all three strain types of T. gondii
block IFN-␥-mediated transcription via STAT1.

Olias and Sibley

was stably expressed in HeLa cells (A) or RAW264.7 macrophages (B). Reporter cell lines were plated in 96-well plates and infected with different MOIs, as
indicated. At 2 h after infection, the cells were stimulated with 100 U of IFN-␥/ml for 18 h. Subsequently, the cells were lysed, and the luciferase activity was
measured. The data shown are means ⫾ standard errors of the mean (SEM) of at least three independent experiments, each with three technical replicates.
Kruskal-Wallis test with Dunn’s correction (***, P ⬍ 0.0001) was performed for GT1 and each of the other T. gondii strains.

incubated with secondary goat anti-rabbit IgG conjugated to Alexa Fluor
594 dye (Invitrogen, Carlsbad, CA). After staining, the slides were
mounted with Prolong Gold plus DAPI (4=,6=-diamidino-2-phenylindole; Life Technologies) and examined with a Zeiss Axioskop 2 MOT Plus
microscope equipped for epifluorescence and using a 63⫻ PlanApochromat lens (numerical aperture [N.A.] of 1.40; Carl Zeiss, Inc., Thornwood,
NY). Images were acquired with an AxioCam MRm camera (Carl Zeiss)
using Axiovision and processed with Gimp 2.8. The mean red fluorescence of IRF1 in host cell nuclei was determined by the use of the ROI
manager in ImageJ. A region of interest (ROI) was selected over DAPIstained host cell nuclei and the unstained background. The corrected
integrated density (CTCF) representing nuclear red fluorescence was calculated by using the following equation: CTCF ⫽ integrated density –
(area of nucleus ⫻ mean fluorescence of background readings). Prism v6
(GraphPad) was used for blotting the results of three biological replicates,
each with 15 technical replicates per condition.
Statistics. Statistical analyses were conducted with Prism v6. The results were compared using the Kruskal-Wallis test or two-sample Student
t tests, as noted (*, P ⬍ 0.05 was considered the minimum cutoff for
significance).

RESULTS

Strain-dependent interference with GAS-FLUC assay. Clonal
type strains of T. gondii (i.e., types I, II, and III) have previously
been reported to equally interfere with the STAT1 signaling pathway and thereby block IFN-␥-dependent gene expression (15, 17).
The exact mechanism of this block is still unknown despite several
attempts to identify a T. gondii effector over the past 2 decades. To
investigate the mechanism of STAT1 inhibition by T. gondii, we
adopted a FLUC reporter system for use in HeLa cells and
RAW267.4 macrophages. At a low MOI, we were unable to detect
a significant strain-dependent difference in HeLa cells, a finding
consistent with previous reports (17). However, at higher MOIs,
the strain GT1 blocked the reporter system more efficiently than
either ME49 or CTG (Fig. 1A). More dramatically, a strong straindependent effect was detected even at lower infection rates in
RAW267.4 macrophages (Fig. 1B). These results led us to suspect
that previous studies had failed to observed a strain-dependent
effect either due to use of different reporter cell lines, lower MOIs,
or a combination of effects.
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QTL analysis maps to a single locus on chromosome XII. To
investigate the observed strain-dependent effect further and to test
whether the phenotype could be mapped to a genomic region, we
took advantage of a previously established cross between GT1 and
ME49 strains (18). We determined the ratio of IFN-␥-dependent
FLUC activity from infected versus noninfected cells for each of 36
recombinant progeny (Fig. 2A). The parental GT1 strain strongly
interfered with the FLUC signal, whereas the parental ME49 strain
was only weakly inhibitory (Fig. 2A). Interestingly, almost all
clones clustered close to one of the parental lineages, suggesting
that a single genomic locus was responsible for the observed phenotype. We analyzed the interference of FLUC activation as a
quantitative trait and mapped the locus to a region of ⬃688 kb on
the right side of chromosome XII (Fig. 2B). Initially, this region
was bounded by recombination between markers 181 and 193, as
typified by progeny SF50 and SF34 (Fig. 2B). In order to narrow
down the region, we identified two new progeny from this cross
(i.e., 2C7C3 and SF59) that were genotyped using a previous set of
markers, as well as new genetic markers defined by direct sequencing of regions within this locus (Fig. 2C). Collectively, the crossovers defined by these progeny identify a region of ⬃263 kb
(TGME49_chrXII: 6559896.0.6822749) on chromosome XII containing 36 genes (http://ToxoDB.org) that was associated with the
observed phenotype (Fig. 2C). Robust multiarray averaging
(RMA) comparison for expression differences between GT1 and
ME49 (25) across this region identified nucleoside triphosphate
hydrolase (NTPase) as differentially expressed with higher levels
being detected in the type I GT1 strain. Closer inspection revealed
that this difference in expression occurred because of differences
in gene copy number. Specially, NTPase I is only present in type I
strains, while NTPase II is found in type I and other strains such as
ME49 (10) (Fig. 3A). Additionally, the type I locus also contains a
pseudogene that is not expressed (Fig. 3A).
Generation of NTPase single- and double-disruptant mutants. To verify that the NTPase locus was responsible for the
mapped phenotypic difference, we used CRISPR/Cas9 technology
(19) to generate single- and double-gene disruptant mutants in
the type I RH strain. Initially, we used a DHFR cassette that confers
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FIG 1 Toxoplasma gondii strain-dependent inhibition of luminescence in IFN-␥-inducible FLUC reporter lines. A tandem GAS element-driven FLUC reporter

Role of NTPases in Toxoplasma

interfere with the GAS-FLUC in RAW264.7 macrophages. The data shown are normalized averages of three technical replicates ⫾ standard deviations (SD). (B
and C) QTL scan of normalized percent inhibition identified a single locus of ⬃688 kb (TGME49_chrXII: 6134501.0.6822749) on chromosome XII defined by
the two markers 181 and 193 and the progeny SF50 and SF34. Fine mapping with additional PCR markers (see Table S2 in the supplemental material) within the
QTL identified two additional informative progeny (2C7C3 and SF59) and narrowed the region responsible for the observed strain difference to ⬃263 kb
(TGME49_chrXII: 6559896.0.6822749) comprising 36 annotated genes.

resistance to pyrimethamine to isolate a gene disruptant mutant
lacking either NTPase I (⌬ntpase I; RH⌬hxgprt/ntpaseI::DHFR) or
NTPase II (⌬ntpase II; RH⌬hxgprt/ntpaseII::DHFR) (Fig. 3A).
Subsequently, a double-disruptant mutant was generated using
an HXGPRT resistance cassette inserted into the NTPase I gene
in the ⌬ntpase II background (⌬ntpase II ⌬ntpase I; RH⌬hxgprt/
ntpaseII::DHFR/ntpaseI::HXGPRT). All mutants were confirmed
by diagnostic PCR (Fig. 3B). To confirm the absence of protein
products in the single or double gene knockouts, we used a polyclonal rabbit antibody that has been raised previously against the
full-length NTPase II protein (23). Western blot data indicate that
in the RH strain NTPase I is more abundant than NTPase II (Fig.
3C). We independently generated a second version (v2) doubleknockout clone using HXGPRT resistance cassette as an insert
(⌬ntpase II ⌬ntpase I v.2, RH⌬hxgprt/ntpaseII::HXGPRT/ntpaseI::
HXGPRT) (Fig. 3A).
Knockouts of NTPase II and I are not essential for growth or
virulence in CD1 mice and do not affect STAT1 transcription.
Since NTPase I is present in type I strains (10), it has been speculated that NTPase I is a primary virulence factor (11). Notably, we
were not able to identify any growth defect in either of the single or
double knockouts in vitro (Fig. 4A). To test whether the absence of
NTPase I or NTPase II, as well as the disruption of both genes,
would have a virulence defect in vivo, we infected CD1 mice. No
significant difference in survival was identified between single and
double knockouts compared to wild-type RH (Fig. 4B). To test
whether NTPase I and NTPase II interfere with the STAT1 pathway, we used IRF1 as IFN-␥-inducible protein marker. Normally,
IRF1 is upregulated by STAT1-mediated transcription, and it accumulates in the nucleus after treatment with IFN-␥; this pathway
is blocked by prior infection with T. gondii (15). Unexpectedly, we
could not identify any difference in the ability to block the IRF1
induction between wild-type RH compared to single and double
NTPase disruptant mutants (Fig. 4C). This finding suggested that
any potential effects of NTPases on the FLUC assay were not due
to disruption of STAT1-mediated transcription but rather to
some interference in the assay.
NTPases I and II were responsible for the ATP-dependent
artifact in firefly luciferase assay. To examine the role of NTPase
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enzymes in luciferase assays, we compared wild-type and mutant
lines in the reporter cell assays. We observed a strong negative
influence of NTPase I on the FLUC activity in both HeLa cells and
RAW264.7 macrophages (Fig. 5A and B). Notably, the NTPase I
knockout in the type I strain mirrors the less inhibitory phenotype
of type II (ME49) and III (CTG) strains, which naturally lack
NTPase I (Fig. 5A and B). In contrast, deletion of NTPase II
showed only a mild change in inhibition of the FLUC assay (Fig.
5A and B). Furthermore, the inhibitor effect of NTPases on the
FLUC assay was partially rescued by adding 20 mM ATP during
host cell lysis and by the absence of dithiol compounds, respectively (Fig. 5C). These findings suggest that the inhibition of FLUC
activity is due to consumption of ATP by the NTPases.
To overcome the limitation of FLUC assays, we implemented
the ATP-independent GLUC as an alternative reporter. Using this
ATP-independent system, the original strain-dependent difference in luciferase activity was no longer apparent. Moreover,
when we compared the NTPase disruptant mutants, they showed
no difference from wild-type T. gondii parasites (Fig. 5D).
DISCUSSION

In this study, we aimed to identify T. gondii effectors responsible
for blocking the IFN-␥ immune response in host cells. Previously,
it has been shown that T. gondii inhibits STAT1-mediated transcription in IFN-␥-activated cells and that different clonal parasite
strain types do so with similar efficiency (15, 17). We developed
multiple GAS-FLUC reporter lines in human and mouse cells and
contrary to previous studies uncovered a strain-dependent inhibition of IFN-␥ signaling. Initially, we attributed this difference to
different reporter cell lines or to the higher MOIs used in our
studies. Based on observing a strong strain-specific difference in
the inhibition of FLUC activity in RAW264.7 macrophages, we
reasoned that this trait was amenable to QTL analysis. We took
advantage of a previous genetic cross (18) and analyzed recombinant progeny based on their ability to inhibit IFN-␥-driven GASFLUC activity in infected macrophages.
Using QTL analysis, we mapped the strain-dependent phenotype to a single locus containing the NTPase I and NTPase II genes,
which have previously been implicated in virulence (10, 11). After
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FIG 2 Mapping of a single target locus on chromosome XII. (A) GT1 (type I) and ME49 (type II) parental strains and 36 progeny were tested for their ability to
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Downloaded from http://iai.asm.org/ on July 23, 2016 by Washington University in St. Louis
FIG 3 Generation and verification of NTPase I and II single- and double-disruptant mutants. (A) Diagram of single NTPase II (⌬ntpase II; RH⌬hxgprt/ntpaseII::

DHFR) and NTPase I (⌬ntpase I; RH⌬hxgprt/ntpaseI::DHFR) mutants and two versions of double-knockout mutants (⌬ntpase II ⌬ntpase I, RH⌬hxgprt/ntpaseII::
DHFR/ntpaseI::HXGPRT; ⌬ntpase II ⌬ntpase I v.2, RH⌬hxgprt/ntpaseII::HXGPRT/ntpaseI::HXGPRT) generated by CRISPR/Cas9 guided gene disruption. The
pseudogene (PG) lacks a suitable start codon and therefore is not transcribed (30). However, it shares complete sequence homology in part with either NTPase
II or I for which reason the guide RNA II targets both NTPase II and the pseudogene resulting in a double cut. The type I RH strain (⌬hxgprt) was the background
for all the mutants described. For the locations and sequences of guides, see Table S3 in the supplemental material. (B) Diagnostic PCR of disruptant mutants with
primer pair locations as indicated in panel A. For primer locations and sequences, see Table S3 in the supplemental material. (C) Western blot analysis of protein
loss in NTPase disruptant mutants. GRA7 served as loading control.
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we identified the QTL on chromosome XII, we narrowed the locus
to a region containing 36 genes. Based on detecting a higher level
of gene expression in the type I GT1 lineage, we reasoned that the
NTPase I and NTPase II genes might indeed be involved in this
phenotype. NTPase I is found only in virulent type I strains
(10), and previous studies have suggested it is refractory to
deletion (11), suggesting that it might play a role in acute virulence. NTPases I and II are located in dense granules and
constitute 2 to 8% of the total tachyzoite protein content (12,
13, 26). It has previously been reported that NTPases might be
involved in tachyzoite egress or purine salvage (27). However, it is
unclear how the NTPases might affect STAT1 signaling, since both
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enzymes are not thought to be released into the host cell cytosol
but rather occupy the parasitophorous vacuole (23).
Despite previous predictions, deletion of the genes encoding
either or both of the NTPase enzymes had no effect on growth or
virulence of T. gondii. Using the highly efficient CRISPR/Cas9
system (19), we were easily able to delete each of the NTPase genes,
as well as generate the double mutant using several different strategies. Although these findings do not rule out another role in
different life cycle stages or different hosts, it is apparent they are
not essential under normal growth conditions or in the murine
model. However, we did confirm that the presence of NTPase I
was associated with greater inhibition of the FLUC assay, thus
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FIG 4 Growth, virulence, and interference with STAT1 pathway. (A) Plaque assay on HFF monolayers examining growth of wild-type and NTPase knockout
parasites. (B) Virulence of NTPase knockout strains in CD-1 mice infected intraperitoneally with 200 tachyzoites per mouse. Groups of five mice per strain were
infected, and the survival was monitored. The experiment was repeated once, and the results of both experiments were plotted together. (C) A fluorescence assay
performed to examine the interference of wild-type T. gondii with IRF1 protein expression as a readout for STAT1-activated transcription compared to NTPase
knockout strains showed no NTPase-dependent effect. HFF monolayers were infected for 2 h and subsequently activated with 100 U of IFN-␥/ml for 5 h.
Quantification of the IRF1 fluorescence of infected cells versus controls. Data points represent the mean red fluorescence in a ROI overlaying the host cell nucleus.
IRF1, red; DAPI, blue; T. gondii-GFP, green. Scale bar, 10 m. ***, P ⬍ 0.0001 (Kruskal-Wallis with Dunn’s correction).

Olias and Sibley

infected with different MOIs for 3 h and subsequently stimulated with 100 U of IFN-␥/ml for 18 h. NTPase I and double-knockout mutants were significantly less
capable at suppressing FLUC activity in both RAW264.7 macrophages (A) and HeLa cells (B) than the wild-type RH strain. Asterisks (*) indicate a P value
of ⬍0.05 between the wild type and NTPase I and double-knockout mutants. (C) The addition of ATP during cell lysis or the absence of DTT in the lysis buffer
partially reversed the interference with the firefly luciferase reporter. Asterisks (*) indicate a P value of ⬍0.05 between cell lysis with or without DTT. (D) An
IFN-␥-inducible tandem GAS element-driven ATP-independent GLUC RAW264.7 macrophage reporter line showed no NTPase-dependent effect. The data
shown are averages ⫾ SEM of at least three independent experiments, each performed with three technical replicates (A, C, and D), and averages ⫾ SD of two
independent experiments with three technical replicates (B).

supporting the original strain-dependent difference we observed.
Consistent with our QTL mapping result, deletion of the NTPase I
gene in the type I RH strain restored levels of FLUC to levels
similar to the ME49 strain, which contains only NTPase II. However, the inhibitory effect observed in the FLUC assay was not due
to blockage of STAT1-induced transcription, as shown by the induction of IRF1 in an immunofluorescence assay. Transcription
of IFN-␥-inducible genes such as IRF1 is initiated after phosphorylated STAT1 homodimers bind to gamma-activated sequence
(GAS) elements in their promoter regions (28). Since IFN-␥-dependent transcription is globally blocked in T. gondii-infected
cells (15, 29), we would have expected this block to be absent in
NTPase knockout strains if these genes were responsible. However, when we examined the ability of NTPase mutants to inhibit
STAT1-induced gene expression, we found that the loss of both
enzymes had no effect. This result led us to suspect that the inhibition of FLUC activity was due to the potent activity of NTPase I
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in consuming ATP, which is necessary for initiation of the light
reaction in several luciferase systems, such as FLUC and click beetle luciferase.
Taken together, the combination of QTL mapping and reverse
genetic approaches using CRISPR/Cas9 confirmed that type I
strains inhibit FLUC to a greater extent and that the NTPase genes
were responsible for this trait. However, the failure of NTPase
mutants to alter IRF1 induction suggested that the original
FLUC assay was not a faithful readout for STAT1 activity. Instead, our findings strongly suggest that ATP hydrolysis by T.
gondii NTPases was responsible for the observed interference with
the FLUC assay. This conclusion is supported by the presence of
NTPase I, which is more strongly expressed and has a higher ATP
hydrolysis rate, in type I strains that show greater potential to
inhibit the FLUC assay. Additional support is provided by the fact
that NTPase activity was enhanced by dithiol compounds such as
DTT (13), a component of our FLUC assay, and addition of ATP
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FIG 5 Influence of NTPases I and II on firefly and Gaussia luciferase reporter lines. IFN-␥-inducible tandem GAS element-driven FLUC reporter lines were
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during cell lysis or DTT-free lysis buffer partially reversed the
inhibition of FLUC activity by T. gondii.
Notably, the enzymatic effect of NTPases was independent of
the species or cell type background of the reporter assay, as reflected by very similar results in both murine RAW264.7 macrophages and human HeLa cells. Hence, the artifact described here is
likely to confound other ATP-dependent assays involving T. gondii infection of host cells. Although the use of T. gondii strains null
for both NTPase I and NTPase II could be used to avoid interference artifacts in ATP-dependent assays, the use of a non-ATPdependent luciferase such as Gaussia luciferase avoids this problem. Therefore, the Gaussia luciferase assay provides the preferred
platform for future studies on gene expression inhibitor screening
and growth assays involving T. gondii.

